Dropropizine

CAS No. 17692-31-8

Dropropizine( Dropropizine )

Catalog No. M12662 CAS No. 17692-31-8

Dropropizine is a racemic non-opiate antitussive agent, it is used as a cough suppressant.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    Dropropizine
  • Note
    Research use only, not for human use.
  • Brief Description
    Dropropizine is a racemic non-opiate antitussive agent, it is used as a cough suppressant.
  • Description
    Dropropizine is a racemic non-opiate antitussive agent, it is used as a cough suppressant.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Dropropizine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    17692-31-8
  • Formula Weight
    236.31
  • Molecular Formula
    C13H20N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 47 mg/mL (198.89 mM); Water: 11 mg/mL (46.54 mM); DMSO: 47 mg/mL (198.89 mM)
  • SMILES
    OCC(O)CN1CCN(C2=CC=CC=C2)CC1
  • Chemical Name
    3-(4-Phenylpiperazin-1-yl)propane-1,2-diol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Slamenova D, et al. Mutat Res, 1986 Mar, 169(3), 171-177.
molnova catalog
related products
  • 2:PN:US20040072744 S...

    2: PN: US20040072744 SEQID: 2 claimed protein is a synthetic peptide, used for the research of Down’s syndrome and schizophrenia.

  • 4'-tert-Butylacetoph...

    Used as pharmaceutical intermediates.

  • Soyasapogenol A

    Soyasapogenol A shows estrogenic and hepatoprotective activities, it directly prevents apoptosis of hepatocytes, and secondly, inhibits the elevation of plasma TNF-α±, which consequently resulted in the prevention of liver damage in the concanavalin A-induced hepatitis model.